Will you have Jamais vu when taking Impatiens capensis and Nabin chanvandi - from FDA reports


There is no Jamais vu reported by people who take Impatiens capensis and Nabin chanvandi yet. This review analyzes which people have Jamais vu with . It is created by eHealthMe based on reports from FDA, and is updated regularly.

What's eHealthMe?

eHealthMe is a health data analysis company based in Mountain View, California. eHealthMe monitors and analyzes the outcomes of drugs and supplements that are currently on the market. The results are readily available to health care professionals and consumers.

eHealthMe has released original studies on market drugs and worked with leading universities and institutions such as IBM, London Health Science Centre, Mayo Clinic, Northwestern University and VA. eHealthMe studies have now been referenced in over 500 peer-reviewed medical publications.

How we gather our data?

Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference.

The information that eHealthMe collects includes:

  • Side effects (including severity and how people recover from them)
  • Associated conditions or symptoms
  • Drug effectiveness
  • Demographic data regarding drug use

How the study uses the data?

The study is based on jewelweed and andrographis (the active ingredients of Impatiens capensis and Nabin chanvandi, respectively), and Impatiens capensis and Nabin chanvandi (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Synonyms of Jamais vu are also considered in the study.

What is Impatiens capensis?

Impatiens capensis has active ingredients of jewelweed.

What is Nabin chanvandi?

Nabin chanvandi has active ingredients of andrographis.

What is jamais vu?

Jamais vu (the experience of being unfamiliar with a person or situation that is actually very familiar; associated with certain types of epilepsy) has been reported by people with psychogenic pain disorder, dissociation, malaria, multiple sclerosis (latest reports from 11 Jamais vu patients).

How to use the study?

Patients can bring a copy of the report to their healthcare provider to ensure that all drug risks and benefits are fully discussed and understood. It is recommended that patients use the information presented as a part of a broader decision-making process.

On Mar, 26, 2019
No report is found.

Do you take Impatiens capensis and Nabin chanvandi?

You are not alone:

Related studies

Drugs that are associated with Jamais vu
Jamais vu
Could your condition cause Jamais vu
Jamais vu

What would happen?

Predict new side effects and undetected conditions when you take Impatiens capensis and Nabin chanvandi

Recent updates

Recent general studies
Recent personal studies

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.